Your browser doesn't support javascript.
loading
Aplasia medular asociada al uso de ticlopidina / Bone marrow aplasia associated to the use of ticlopidine: report of one case
Ruiz B., Carolina; Monroy A., Tatiana; Montaña N., Nelson; Lora L., Pilar; Lamich B., Rubén; Valderrama R., Alejandro.
Affiliation
  • Ruiz B., Carolina; s.af
  • Monroy A., Tatiana; s.af
  • Montaña N., Nelson; Hospital Barros Luco Trudeau. Unidad de Tratamiento Intermedio.
  • Lora L., Pilar; Hospital Barros Luco Trudeau. Unidad de Tratamiento Intermedio.
  • Lamich B., Rubén; Hospital Barros Luco Trudeau. Unidad de Tratamiento Intermedio.
  • Valderrama R., Alejandro; Hospital Barros Luco Trudeau. Unidad de Tratamiento Intermedio.
Rev. méd. Chile ; 130(7): 798-802, jul. 2002. tab, graf
Article de Es | LILACS | ID: lil-323256
Bibliothèque responsable: CL1.1
RESUMO
We report a 58 years old male that developed a bone marrow aplasia associated to the use of ticlopidine, prescribed after coronary artery stenting. The patient developed a pneumonia as a complication. He was admitted to the Intermediate Treatment Unit, receiving wide spectrum antimicrobial therapy and a granulocyte colony stimulating factor (Neupogen(r)) with favourable response. Ticlodipine is an effective anti-platelet agent, but has serious hematological and other side effects. Its prescription requires a close follow up and search for complications
Sujet(s)
Texte intégral: 1 Indice: LILACS Sujet Principal: Maladies de la moelle osseuse / Ticlopidine Type d'étude: Risk_factors_studies Limites du sujet: Humans / Male langue: Es Texte intégral: Rev. méd. Chile Thème du journal: MEDICINA Année: 2002 Type: Article
Texte intégral: 1 Indice: LILACS Sujet Principal: Maladies de la moelle osseuse / Ticlopidine Type d'étude: Risk_factors_studies Limites du sujet: Humans / Male langue: Es Texte intégral: Rev. méd. Chile Thème du journal: MEDICINA Année: 2002 Type: Article